(Q28193251)

English

Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction

scientific article (publication date: May 2002)

In more languages

Statements

scholarly article

0 references

Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction (English)

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

unstable angina

1 reference

based on heuristic

inferred from title

3

object named as

Lars Wallentin

0 references

2

object named as

Eva Swahn

0 references

author name string

Filip Jacobsson

1

0 references

Mikael Ellborg

4

0 references

language of work or name

0 references

publication date

May 2002

0 references

Clinical Therapeutics

0 references

24

0 references

5

0 references

752-65

0 references

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)85149-9

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28193251&oldid=2113652266"